ey0021.11-14 | Adipocyte Dysfunction and Obesity Related Comorbidities | ESPEYB21
W Xia , P Veeragandham , Y Cao , Y Yayun Xu , TE Rhyne , J Qian , Hung Chao-Wei , P CHZhao , Y Jones , H Hui Gao , C Liddle , RT Yu , M Downes , RM Evans , M Ryden , M Wabitsch , Z Wang , H Hakozaki , J Schoneberg , SM Reilly , J Huang , AR Saltiel
ey0021.11-15 | Adipocyte Dysfunction and Obesity Related Comorbidities | ESPEYB21
F Klingelhuber , S Frendo-Cumbo , M Omar-Hmeadi , L Massier , P Kakimoto , AJ Taylor , M Couchet , S Ribicic , M Wabitsch , AC Messias , A Iuso , TD Muller , M Ryden , N Mejhert , N Krahmer
ey0021.11-16 | Adipocyte Dysfunction and Obesity Related Comorbidities | ESPEYB21
M Šiklova , V Šramkova , M Koc , E Krauzova , T Čižkova , B Ondrůjova , M Wilhelm , Z Varaliova , O Kuda , J Neubert , L Lambert , M Elkalaf , J Gojda , L Rossmeislova
ey0021.11-17 | Adipocyte Dysfunction and Obesity Related Comorbidities | ESPEYB21
M Chiriaco , L Nesti , A Flyvbjerg , A Golay , J-A Nazare , C-H Anderwald , A Mitrakou , R Bizzotto , A Mari , A Natali